Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03314129 · ClinicalTrials.gov registry record · NA
Remediation of Visual Perceptual Impairments in People With Schizophrenia
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT03314129: Completed NA study, sponsored by University of Rochester.
NCT03314129 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03314129, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a visual remediation intervention for people with schizophrenia. The intervention targets two visual functions that much research has shown are impaired in many people with the disorder, namely contrast sensitivity and perceptual organization. The first phase of the study will test the effects of interventions targeting each of these processes, as well as the effects of a combined package. A control condition of higher-level cognitive remediation is included as a fourth condition. The second phase of the study will evaluate the effectiveness of the most effective intervention from the first phase, but in a new and larger sample of individuals. Outcome measures include multiple aspects of visual functioning, as well as visual cognition and overall community functioning.
Primary Outcome
Peak contrast, as measures by a behavioral (psychophysical) measure of contrast sensitivity.
Interventions
- BEHAVIORAL UltimEyes
- BEHAVIORAL Contour Integration Training
- BEHAVIORAL UltimEyes + Contour Integration Training
- BEHAVIORAL MyBrainSolutions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What the finished NCT03314129 record still lists
NCT03314129 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which UltimEyes is the first listed.
NCT03314129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03314129 about?
NCT03314129 is a clinical study titled "Remediation of Visual Perceptual Impairments in People With Schizophrenia". The purpose of this study is to evaluate the effectiveness of a visual remediation intervention for people with schizophrenia. The intervention targets two visual functions that much research has shown are impaired in many people with the disorder, namely contrast sensitivity and perceptual organiza...
What is the current status of trial NCT03314129?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2018-06-01. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT03314129?
The interventions under investigation include: UltimEyes (BEHAVIORAL), Contour Integration Training (BEHAVIORAL), UltimEyes + Contour Integration Training (BEHAVIORAL), MyBrainSolutions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03314129?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03314129's enrollment target sits among peer trials
79 1060th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI